Facts & figures

As of: January, 2016
1) primarily from public funds (EU, Federal Government, State Government); according to Campus Buch: total funding since 1992
2) primarily from own ressources, since 2001

3) primarily from own ressources

4) since 2009
5)since 2006

Research Institutions of Campus Berlin-Buch Employees (total)	2,091
of these:
Max Delbrück Center for Molecular Medicine (MDC):	1,624
Leibniz Institute of Molecular Pharmacology (FMP):	275
Klinische Forschung Charité Campus Buch:	192

Budget and third-party grants (total)1	EUR 144 million
Max Delbrück Center for Molecular Medicine (MDC):	EUR 104 million
Leibniz Institute of Molecular Pharmacology (FMP):	EUR 24 million
Klinische Forschung Charité Campus Buch:	EUR 16 million

BiotechPark Berlin-Buch
Number of companies:	63
Employees:	800
Annual revenue: Percentage of third-party grants: 3,1%	EUR 160 million

Hospitals & Patient-Care Institutions
Employees (total): of these:	3,398
HELIOS Klinikum Berlin-Buch:	2,550
Evangelische Lungenklinik:	314
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik):	84
Patient-care institutions:	450
Number of patient beds:	1232
Patients per year (inpatient and outpatient):	199,400

Total investment volume of these:	EUR 1.219 billion
Infrastructure Campus Berlin-Buch1	EUR 502 million
HELIOS Klinikum Berlin-Buch²	EUR 304 million
Evangelische Lungenklinik3	EUR 49 million
Immanuel Krankenhaus Berlin, Standort Buch (Rheumaklinik)1	EUR 38 million
LudwigPark3	EUR 45 million
Allées des Châteaux3	EUR 23 million
Widerker Vermögensverwaltung (Schlosspark-Passage)3	EUR 28 million
Housing construction associations (HOWOGE3,4, EWG3,5, Hau+S3,5)	EUR 120 million
Ludwig Hoffmann Quartier	EUR 110 million

News Buch Berlin

Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care

Seed implantation for prostate cancer is now to be reimbursed as an outpatient treatment by public health insurances in Germany. This was decided by the Federal Joint Committee (G-BA) with effect from...

more ...

Enhanced speed, contrast, and information: New contrast mechanism improves xenon MRI

Xenon magnetic resonance imaging offers deep insights into the human body and opens up new possibilities in the diagnosis and treatment of diseases.

more ...

A potent weapon against lymphomas

MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular l...

more ...